Background: Protein-tyrosine phosphatases (PTPs) are critical regulators of phosphorylation signaling. Results: Zinc(II) ions are reversible inhibitors of receptor PTP with a remarkably low K i of 21 Ϯ 7 pM.
Conclusion:The inhibition implicates cellular zinc(II) ions as physiological regulators of PTPs. Significance: The results suggest that zinc modulates signal transduction in endothelial cells affecting angiogenesis and wound healing.As key enzymes in the regulation of biological phosphorylations, protein-tyrosine phosphatases are central to the control of cellular signaling and metabolism. Zinc(II) ions are known to inhibit these enzymes, but the physiological significance of this inhibition has remained elusive. Employing metal buffering for strict metal control and performing a kinetic analysis, we now demonstrate that zinc(II) ions are reversible inhibitors of the cytoplasmic catalytic domain of the receptor protein-tyrosine phosphatase  (also known as vascular endothelial protein-tyrosine phosphatase). The K i(Zn) value is 21 ؎ 7 pM, 6 orders of magnitude lower than zinc inhibition reported previously for this enzyme. It exceeds the affinity of the most potent synthetic small molecule inhibitors targeting these enzymes. Inhibition is in the range of cellular zinc(II) ion concentrations, suggesting that zinc regulates this enzyme, which is involved in vascular physiology and angiogenesis. Thus, for some enzymes that are not recognized as zinc metalloenzymes, zinc binding inhibits rather than activates as in classical zinc enzymes. Activation then requires removal of the inhibitory zinc.Phosphatases are major control enzymes in phosphorylation signaling, and they do not simply oppose the action of kinases (1). Protein-tyrosine phosphatases (PTPs) 2 are one subfamily of phosphatases. The human genome contains 107 PTPs that belong to families of soluble (nonreceptor-type) and membrane-resident (receptor-type) proteins (2). PTPs have pivotal functions in cellular processes and are extensively regulated. At the protein level, this regulation includes redox modulation, phosphorylation, sumoylation, dimerization, and proteolysis (3). With the exception of class IV PTPs, the catalytic group in their active sites is a cysteine with a remarkably low thiol pK a (about 4.4 -5.5 in PTP-1B). The cysteine forms a phosphoenzyme intermediate in the reaction with substrate. Redox modulation of PTP-1B involves oxidation of the catalytic cysteine to a sulfenic acid, which reacts with a backbone nitrogen of an adjacent serine to form a cyclic sulfenyl amide (4, 5). Other PTPs are redox-modulated differently. They form a disulfide between the two "backdoor" cysteines or between the catalytic cysteine and one of the backdoor cysteines (6, 7). Vanadium compounds and zinc(II) ions are classical inhibitors of PTPs. Meta-and orthovanadate mimic the phosphate group in the transition states of the enzyme and therefore have been valuable in delineating the reaction mechanism (8). In contrast to vanadium, zinc is nutritionally esse...